Anna Offersgaard

693 citations

18 papers · 406 indexed · 1 hit paper · h-index 11

Impact in

Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
Hepatology top 10%
- Hepatitis C virus research

Papers in ⓘ

Infectious Diseases 9
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 detection and testing 3
Hepatology 9
- Hepatitis C virus research 9

Co-authors: Judith M. Gottwein (18 shared papers)Jens Bukh (18 shared papers)Ulrik Fahnøe (13 shared papers)Santseharay Ramírez (8 shared papers)Yuyong Zhou (8 shared papers)Karen Anbro Gammeltoft (8 shared papers)Long V. Pham (7 shared papers)Shan Feng (6 shared papers)
Journals: Scientific Reports (4 papers)Vaccines (3 papers)Viruses (2 papers)iScience (1 paper)Journal of Hepatology (1 paper)
Partner nations: Denmark Germany United States

In The Last Decade

Anna Offersgaard

17 papers receiving 402 citations

Hit Papers

align trajectories log scale

Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system 2022 · 132 citations

Peers

Countries citing papers authored by Anna Offersgaard

Since Specialization

Citations

This map shows the geographic impact of Anna Offersgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Offersgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Offersgaard more than expected).

Fields of papers citing papers by Anna Offersgaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Offersgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Offersgaard. The network helps show where Anna Offersgaard may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Offersgaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Offersgaard Line = papers co-authored together Anna Offersgaard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system Science Advances ·Yuyong Zhou, Karen Anbro Gammeltoft, Line A. Ryberg, Long V. Pham, Helena D. Tjørnelund, Alekxander Binderup, Carlos Rene Duarte Hernandez, Carlota Fernandez-Antunez, Anna Offersgaard, Ulrik Fahnøe, Günther H. Peters, Santseharay Ramírez, Jens Bukh, Judith M. Gottwein Hit paper breakdown →	2022	132
2	In vitro efficacy of artemisinin-based treatments against SARS-CoV-2 Scientific Reports ·Yuyong Zhou, Kerry Gilmore, Santseharay Ramírez, Eva Settels, Karen Anbro Gammeltoft, Long V. Pham, Ulrik Fahnøe, Shan Feng, Anna Offersgaard, Jakob Trimpert, Jens Bukh, Nikolaus Osterrieder, Judith M. Gottwein, Peter H. Seeberger	2021	70
3	Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro Antimicrobial Agents and Chemotherapy ·Karen Anbro Gammeltoft, Yuyong Zhou, Carlos R. Duarte Hernandez, Andrea Galli, Anna Offersgaard, Rui Costa, Long V. Pham, Ulrik Fahnøe, Shan Feng, Troels K. H. Scheel, Santseharay Ramírez, Jens Bukh, Judith M. Gottwein	2021	37
4	Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine Scientific Reports ·Keven Lothert, Anna Offersgaard, Anne Finne Pihl, Christian K. Mathiesen, Tanja B. Jensen, Garazi Peña Alzua, Ulrik Fahnøe, Jens Bukh, Judith M. Gottwein, Michael W. Wolff	2020	25
5	Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro Viruses ·Yuyong Zhou, Karen Anbro Gammeltoft, Andrea Galli, Anna Offersgaard, Ulrik Fahnøe, Santseharay Ramírez, Jens Bukh, Judith M. Gottwein	2021	24
6	Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency Vaccines ·Anna Czarnota, Anna Offersgaard, Anne Finne Pihl, Jannick Prentoe, Jens Bukh, Judith M. Gottwein, Krystyna Bieńkowska-Szewczyk, Katarzyna Grzyb	2020	19
7	Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice Journal of Hepatology ·Anne Finne Pihl, Shan Feng, Anna Offersgaard, Garazi Peña Alzua, Elias H. Augestad, Christian K. Mathiesen, Tanja B. Jensen, Henrik Krarup, Mansun Law, Jannick Prentoe, Jan Pravsgaard Christensen, Jens Bukh, Judith M. Gottwein	2022	16
8	Toward a vaccine against hepatitis C virus Science ·Anna Offersgaard, Jens Bukh, Judith M. Gottwein	2023	15
9	SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor Vaccines ·Anna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, Rui Costa, Nandini Venkatesan, Xiangliang Lin, Long V. Pham, Shan Feng, Ulrik Fahnøe, Troels K. H. Scheel, Santseharay Ramírez, Udo Reichl, Jens Bukh, Yvonne Genzel, Judith M. Gottwein	2021	15
10	Inactivated genotype 1a, 2a and 3a HCV vaccine candidates induced broadly neutralising antibodies in mice Gut ·Garazi Peña Alzua, Anne Finne Pihl, Anna Offersgaard, Carlos Rene Duarte Hernandez, Z. H. Duan, Shan Feng, Ulrik Fahnøe, Christina Sølund, Nina Weis, Mansun Law, Jannick Prentoe, Jan Pravsgaard Christensen, Jens Bukh, Judith M. Gottwein	2022	13
11	High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals Scientific Reports ·Anne Finne Pihl, Anna Offersgaard, Christian K. Mathiesen, Jannick Prentoe, Ulrik Fahnøe, Henrik Krarup, Jens Bukh, Judith M. Gottwein	2018	11
12	Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir Viruses ·Karen Anbro Gammeltoft, Yuyong Zhou, Line A. Ryberg, Long V. Pham, Alekxander Binderup, Carlos Rene Duarte Hernandez, Anna Offersgaard, Ulrik Fahnøe, Günther H. Peters, Santseharay Ramírez, Jens Bukh, Judith M. Gottwein	2023	10
13	Identification of novel neutralizing determinants for protection against HCV Hepatology ·Garazi Peña Alzua, Anne Finne Pihl, Anna Offersgaard, Rodrigo Velázquez‐Moctezuma, Carlos R. Duarte Hernandez, Elias H. Augestad, Ulrik Fahnøe, Christian K. Mathiesen, Henrik Krarup, Mansun Law, Jannick Prentoe, Jens Bukh, Judith M. Gottwein	2022	6
14	An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals iScience ·Anna Offersgaard, Carlos Rene Duarte Hernandez, Shan Feng, Pavel Marichal‐Gallardo, Kenn Holmbeck, Anne Finne Pihl, Carlota Fernandez-Antunez, Garazi Peña Alzua, Katrine Top Hartmann, Long V. Pham, Yuyong Zhou, Karen Anbro Gammeltoft, Ulrik Fahnøe, Uffe Vest Schneider, Gabriel Kristian Pedersen, Henrik Elvang Jensen, Jan Pravsgaard Christensen, Santseharay Ramírez, Jens Bukh, Judith M. Gottwein	2023	5
15	High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor Vaccines ·Anna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, Nandini Venkatesan, Henrik Krarup, Xiangliang Lin, Udo Reichl, Jens Bukh, Yvonne Genzel, Judith M. Gottwein	2022	4
16	Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412–425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like Particles Microbiology Spectrum ·Anna Czarnota, Anna Offersgaard, Ania M. Owsianka, Garazi Peña Alzua, Jens Bukh, Judith M. Gottwein, Arvind H. Patel, Krystyna Bieńkowska-Szewczyk, Katarzyna Grzyb	2023	3
17	An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals Scientific Reports ·Anna Offersgaard, Carlos R. Duarte Hernandez, Yuyong Zhou, Z. H. Duan, Karen Anbro Gammeltoft, Katrine Top Hartmann, Ulrik Fahnøe, Pavel Marichal‐Gallardo, Garazi Peña Alzua, Alexander P. Underwood, Christina Sølund, Nina Weis, Jesper Bonde, Jan Pravsgaard Christensen, Gabriel Kristian Pedersen, Henrik Elvang Jensen, Kenn Holmbeck, Jens Bukh, Judith M. Gottwein	2024	1
18	SARS-CoV-2 Mpro inhibitor ensitrelvir: asymmetrical cross-resistance with nirmatrelvir and emerging resistance hotspots Emerging Microbes & Infections ·Yuyong Zhou, Karen Anbro Gammeltoft, Helena D. Tjørnelund-Sjursen, Line A. Ryberg, Anna Offersgaard, Anna Czarnota, Z. H. Duan, Long V. Pham, Ulrik Fahnøe, Günther H. Peters, Santseharay Ramírez, Jens Bukh, Judith M. Gottwein	2025	0

About Anna Offersgaard

Anna Offersgaard is a scholar working on Infectious Diseases, Hepatology, Epidemiology, Animal Science and Zoology and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 406 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (8 papers), Animal Virus Infections Studies (4 papers), COVID-19 Clinical Research Studies (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Computational Drug Discovery Methods (3 papers) and SARS-CoV-2 detection and testing (3 papers). The work is most often cited by research in Infectious Diseases (226 citations), Hepatology (74 citations), Computational Theory and Mathematics (97 citations), Virology (18 citations) and Animal Science and Zoology (36 citations). Anna Offersgaard has collaborated with scholars based in Denmark, Germany and United States. Frequent co-authors include Judith M. Gottwein, Jens Bukh, Ulrik Fahnøe, Santseharay Ramírez, Yuyong Zhou, Karen Anbro Gammeltoft, Long V. Pham, Shan Feng, Alekxander Binderup and Günther H. Peters. Their work appears in journals such as Scientific Reports, Vaccines, Viruses, iScience and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact